Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3681
-0.0004 (-0.11%)
At close: Jul 11, 2025, 4:00 PM
0.3698
+0.0017 (0.46%)
After-hours: Jul 11, 2025, 6:48 PM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.52 million as of July 11, 2025. Its market cap has decreased by -87.26% in one year.
Market Cap
8.52M
Enterprise Value
-12.64M
1-Year Change
-87.26%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.52M, a decrease of -96.67%. That is a compound annual growth rate of -82.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 8.52M | -25.88% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |